We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Fund managers haven’t disclosed any holdings of ASPX yet.

ASPX Hedge Fund Activity: Q2 2015 in Review

0 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q2 2015, worth a combined $0 — down 100% from $1.91B a quarter earlier.

Sellers outnumbered buyers: 138 funds closed out of ASPX and 0 opened new positions — a net loss of 138 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $446M sold.

  • 0 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q2 2015, down from 138 in Q1 2015.
  • Funds reported $0 of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q2 2015 and 138 closed out, a net change of -138 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q2 2015 was Deerfield Management, an estimated $446M sold.

Based on aggregated 13F filings for Q2 2015.